Ann: PrIME Receives Plasma Importation License , page-3

re: Ann: PrIME Receives Plasma Importation Li... K,

This is a real success.

This proves that they can fill out an application form correctly (unlike the PRIME spinoff documentation for which we're still waiting to hear).

And you are wrong, when you say "For around 2 years". Actually, it is closer to 3 years, than 2 years.

November 24, 2010. http://www.nusep.com/user_files/1301975564_NuSep%20Enters%201%20Billion%20Asian%20Blood%20Plasma%20Market.pdf

In this announcement, it was stated "NuSep is also pleased to announce that a leading Singapore cornerstone investor will invest S$3 million in SingaPharm. The total investment required to set up the manufacturing facility and fund clinical trials of SingaPharm’s mini-mill concept is S$12m. Singapore’s Health Sciences Authority (HSA) has reviewed SingaPharm’s technology and clinical trials will commence shortly. The trials are short term in nature (12 months to complete) and involve 40 patients." Correct me if I am wrong, but 12 months has passed since then, a few times.

And the factually challenged wonder why we are sceptical of a funding announcement where an un-named investor will put in "up to $20m" maybe. We had an un-named cornerstone investor back in 2010 that evaporated like the money we shareholders have put in over time.

History suggests that the current funding arrangement will disappear for whatever excuse is provided, if any at all.

K, I think you're spot on. This cGMP application should have been well and truly done and dusted by now. Why not?

I guess the market price, rather than the ambitious predictions of a few, reflect the reality, rather than the dream.